Literature DB >> 7745700

Inducible and conditional inhibition of human immunodeficiency virus proviral expression by vesicular stomatitis virus matrix protein.

S Y Paik1, A C Banerjea, G G Harmison, C J Chen, M Schubert.   

Abstract

Besides its role in viral assembly, the vesicular stomatitis virus (VSV) matrix (M) protein causes cytopathic effects such as cell rounding (D. Blondel, G. G. Harmison, and M. Schubert, J. Virol. 64:1716-1725, 1990). DNA cotransfection assays demonstrated that VSV M protein was able to inhibit the transcription of a reporter gene (B. L. Black and D. S. Lyles, J. Virol. 66:4058-4064, 1992). We have confirmed these observations by using cotransfections with an infectious clone of human immunodeficiency virus type 1 (HIV-1) and found that the amino-terminal 32 amino acids of M protein which are essential for viral assembly were not required for this inhibition. For the study of the potential role of M protein in the shutoff of transcription from chromosomal DNA, we have isolated stable HeLa T4 cell lines which encode either a wild-type or a temperature-sensitive (ts) VSV M gene under control of the HIV-1 long terminal repeat promoter. Transcription of the M mRNA was transactivated after HIV-1 infections. A cell line which encodes the wild-type M protein was nonpermissive for either HIV-1 or HIV-2. A cell line that encodes the ts M gene was transfected with the infectious HIV-1 DNA or was infected with HIV-1 or HIV-2. In all cases, at 32 degrees C, the permissive temperature for M protein, the cells were nonpermissive for HIV replication. At 40 degrees C, the ts M protein was nonfunctional and both HIV-1 and HIV-2 were able to replicate at high levels. A comparison of the amounts of proviral HIV-1 DNAs and HIV-1 mRNAs at 10 and 36 h after HIV-1 infection demonstrated that proviral insertion had not been prevented by M protein and that the block in HIV-1 replication was at the level of proviral expression. The severe reduction of HIV-1 proviral transcripts demonstrates that the VSV M protein alone can inhibit expression from chromosomal DNA. These results strongly support the hypothesis that the VSV M protein is involved in the shutoff of host cell transcription. M protein was able to attenuate HIV-1 infections and protect the cell population from HIV-1 pathogenesis. The temperature-dependent switch from a persistent to a lytic HIV-1 infection in the presence of ts M protein could be useful for studies of HIV-1 replication and pathogenesis.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7745700      PMCID: PMC189066          DOI: 10.1128/JVI.69.6.3529-3537.1995

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  40 in total

1.  Expression of the M gene of vesicular stomatitis virus cloned in various vaccinia virus vectors.

Authors:  Y Li; L Z Luo; R M Snyder; R R Wagner
Journal:  J Virol       Date:  1988-03       Impact factor: 5.103

2.  Genetic characteristics of conditional lethal mutants of vesicular stomatitis virus induced by 5-fluorouracil, 5-azacytidine, and ethyl methane sulfonate.

Authors:  C R Pringle
Journal:  J Virol       Date:  1970-05       Impact factor: 5.103

3.  Hygromycin B phosphotransferase as a selectable marker for DNA transfer experiments with higher eucaryotic cells.

Authors:  K Blochlinger; H Diggelmann
Journal:  Mol Cell Biol       Date:  1984-12       Impact factor: 4.272

4.  Nucleotide sequences of the mRNA's encoding the vesicular stomatitis virus G and M proteins determined from cDNA clones containing the complete coding regions.

Authors:  J K Rose; C J Gallione
Journal:  J Virol       Date:  1981-08       Impact factor: 5.103

5.  Expression of a recombinant DNA gene coding for the vesicular stomatitis virus nucleocapsid protein.

Authors:  J Sprague; J H Condra; H Arnheiter; R A Lazzarini
Journal:  J Virol       Date:  1983-02       Impact factor: 5.103

6.  Trans-acting transcriptional regulation of human T-cell leukemia virus type III long terminal repeat.

Authors:  J Sodroski; C Rosen; F Wong-Staal; S Z Salahuddin; M Popovic; S Arya; R C Gallo; W A Haseltine
Journal:  Science       Date:  1985-01-11       Impact factor: 47.728

7.  Altered cytoplasmic domains affect intracellular transport of the vesicular stomatitis virus glycoprotein.

Authors:  J K Rose; J E Bergmann
Journal:  Cell       Date:  1983-09       Impact factor: 41.582

8.  Role of the vesicular stomatitis virus matrix protein in maintaining the viral nucleocapsid in the condensed form found in native virions.

Authors:  W W Newcomb; J C Brown
Journal:  J Virol       Date:  1981-07       Impact factor: 5.103

9.  Interaction of wild-type and mutant M protein vesicular stomatitis virus with nucleocapsids in vitro.

Authors:  T Wilson; J Lenard
Journal:  Biochemistry       Date:  1981-03-03       Impact factor: 3.162

10.  Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease.

Authors:  J M Chirgwin; A E Przybyla; R J MacDonald; W J Rutter
Journal:  Biochemistry       Date:  1979-11-27       Impact factor: 3.162

View more
  18 in total

Review 1.  Cytopathogenesis and inhibition of host gene expression by RNA viruses.

Authors:  D S Lyles
Journal:  Microbiol Mol Biol Rev       Date:  2000-12       Impact factor: 11.056

2.  Infectious hematopoietic necrosis virus matrix protein inhibits host-directed gene expression and induces morphological changes of apoptosis in cell cultures.

Authors:  P P Chiou; C H Kim; P Ormonde; J A Leong
Journal:  J Virol       Date:  2000-08       Impact factor: 5.103

3.  Matrix protein and another viral component contribute to induction of apoptosis in cells infected with vesicular stomatitis virus.

Authors:  S A Kopecky; M C Willingham; D S Lyles
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

4.  Mutations in the PPPY motif of vesicular stomatitis virus matrix protein reduce virus budding by inhibiting a late step in virion release.

Authors:  H R Jayakar; K G Murti; M A Whitt
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

5.  The vesicular stomatitis virus matrix protein inhibits NF-κB activation in mouse L929 cells.

Authors:  Andrew J Varble; Christopher D Ried; Warren J Hammond; Kaitlin A Marquis; Matthew C Woodruff; Maureen C Ferran
Journal:  Virology       Date:  2016-09-17       Impact factor: 3.616

6.  Effect of vesicular stomatitis virus matrix protein on transcription directed by host RNA polymerases I, II, and III.

Authors:  M Ahmed; D S Lyles
Journal:  J Virol       Date:  1998-10       Impact factor: 5.103

7.  Phenotypic consequences of rearranging the P, M, and G genes of vesicular stomatitis virus.

Authors:  L A Ball; C R Pringle; B Flanagan; V P Perepelitsa; G W Wertz
Journal:  J Virol       Date:  1999-06       Impact factor: 5.103

8.  The matrix protein of vesicular stomatitis virus inhibits nucleocytoplasmic transport when it is in the nucleus and associated with nuclear pore complexes.

Authors:  J M Petersen; L S Her; V Varvel; E Lund; J E Dahlberg
Journal:  Mol Cell Biol       Date:  2000-11       Impact factor: 4.272

9.  Identification of two additional translation products from the matrix (M) gene that contribute to vesicular stomatitis virus cytopathology.

Authors:  Himangi R Jayakar; Michael A Whitt
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

10.  The cell-rounding activity of the vesicular stomatitis virus matrix protein is due to the induction of cell death.

Authors:  Sarah A Kopecky; Douglas S Lyles
Journal:  J Virol       Date:  2003-05       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.